Litcius/Paper detail

An Antiviral Role for TRIM14 in Ebola Virus Infection

Makoto Kuroda, Peter Halfmann, Larissa B. Thackray, Michael Diamond, Heinz Feldmann, Andrea Marzi, Yoshihiro Kawaoka

2023The Journal of Infectious Diseases12 citationsDOIOpen Access PDF

Abstract

Ebola virus (EBOV) is a highly pathogenic virus that encodes 7 multifunctional structural proteins. Multiple host factors have been reported to interact with the EBOV proteins. Here, we found that tripartite motif-containing 14 (TRIM14), an interferon-stimulated gene that mediates cellular signaling pathways associated with type I interferon and inflammatory cytokine production, interacts with EBOV nucleoprotein to enhance interferon-β (IFN-β) and nuclear factor-κB (NF-κB) promotor activation. Moreover, TRIM14 overexpression reduced viral replication in an infectious but biologically contained EBOVΔVP30 system by approximately 10-fold without affecting viral protein expression. Furthermore, TRM14-deficient mice were more susceptible to mouse-adapted EBOV infection than wild-type mice. Our data suggest that TRIM14 is a host factor with anti-EBOV activity that limits EBOV pathogenesis.

Topics & Concepts

Ebola virusNucleoproteinVirologyInterferonBiologyVirusEbolavirusViral replicationCytokineImmunologyViral Infections and Outbreaks ResearchViral Infections and Vectorsinterferon and immune responses
An Antiviral Role for TRIM14 in Ebola Virus Infection | Litcius